Revenue
2013
2014
2015
2016
2017
2018
2019
2020
Nu-Med Plus, Inc. (NUMD)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2012
2013
2014
2015
2017
2018
2019
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & development | — | — | — | — | — | — | — | — | — | — | — | — | $66,214 | $22,134 |
| Operating expenses | $48,955 | $63,331 | $120,526 | $182,167 | $839,445 | $2.0M | $1.0M | $1.2M | $466,519 | $1.2M | $946,478 | $1.1M | $233,636 | $258,227 |
| Operating income | −$48,955 | −$63,331 | −$120,526 | −$182,167 | −$839,445 | −$2.0M | −$1.0M | −$1.2M | −$466,519 | −$1.2M | −$946,478 | −$1.1M | −$233,636 | −$258,227 |
| EBITDAderived | — | — | — | −$179,900 | −$830,080 | −$2.0M | −$1.0M | −$1.2M | −$453,976 | −$1.2M | −$939,329 | −$1.1M | −$230,441 | −$256,410 |
| Net income | −$56,182 | −$68,345 | −$125,526 | −$130,167 | −$830,061 | −$2.0M | −$1.0M | −$1.2M | $3.6M | $9.7M | −$8.9M | −$1.2M | −$332,290 | −$262,744 |
| Basic EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.04 | -$0.02 | -$0.03 | $0.10 | $0.26 | -$0.25 | -$0.04 | -$0.01 | -$0.01 |
| Diluted EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.04 | -$0.02 | -$0.03 | $0.05 | $0.13 | -$0.25 | -$0.04 | -$0.01 | -$0.01 |